Ministry of Health Prosecution

Announcement

The directors of Promisia Integrative Limited (NZX:PIL) advise that the Ministry of Health has
initiated a prosecution against the company alleging that Arthrem, the company’s joint
support product, is an unlicensed medicine and that some marketing activities have been in
breach of the Medicines Act 1981.

There are 9 charges, all of which are based on the Ministry of Health’s view that Arthrem
has been sold and advertised for therapeutic purpose and is thus a medicine.

Promisia disputes all charges and will defend them vigorously.

Arthrem is not a medicine. It is a dietary supplement. Promisia has always ensured that its
advertising is approved under the dietary supplement category.

The Therapeutic Advertising Pre-vetting Service (TAPS) has been used for this approval
process and approval numbers have been obtained for each advertisement, regardless of
the format or platform that it has been displayed on.

Promisia will update the market as this matter progresses but notes that further
information may be affected by the legal process.


Rene de Wit
CEO
021 571000